Conditioned medium derived from mesenchymal stem cells and spinal cord injury: A review of the current therapeutic capacities
Spinal cord injury (SCI) is a debilitating condition of the nervous system that imposes considerable challenges for subjects, such as bladder and bowel incontinence and infections. The standard therapeutic strategy is methylprednisolone utilization accompanied by surgical decompression. However, ach...
Saved in:
Main Authors: | Gholam Reza Kaka, Farrokh Modarresi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-06-01
|
Series: | IBRO Neuroscience Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242125000223 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research Progress on Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis
by: GONG Jin, et al.
Published: (2025-01-01) -
Research Progress on Biomaterials for Spinal Cord Repair
by: Liao Z, et al.
Published: (2025-02-01) -
THE EFFECT OF PLATELET RICH PLASMA ON MESENCHYMAL STEM CELLs (MSCs) DIFFERENTIATION INTO CHONDROBLAST
by: Dwikora Novembri Utomo, et al.
Published: (2019-12-01) -
Epidemiology of spinal cord injuries in three selected counties in Kenya
by: George M. Muli, et al.
Published: (2025-01-01) -
Review of presentations and radiotherapy outcomes of patients with malignant spinal cord compression
by: Louisa M. Mbokazi, et al.
Published: (2025-01-01)